Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2025.
-
Busy address KBO
18 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
PHARMACIE DU VALDUC from Ciney, company number BE0462999311, closed financial year 2025 with a result of € 40,480 after tax. For that financial year PHARMACIE DU VALDUC recorded a gross margin of € 204,795 and equity of € 440,811. Compared with financial year 2024, the result moved from € 20,750 to € 40,480. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 26, 2026.
€ 440,811
▼ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 40,480
▲ 95% vs 2024
Profit after tax over the fiscal year.
€ 161,002
▼ 5% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 90,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
1.5
Average over the fiscal year, from the social balance sheet.
€ 114,874
▲ 2% vs 2024
€ 76,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 4,798
▼ 17% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 31,560
▼ 16% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 15,600
▼ 1% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 169,920 | € 188,795 | € 179,634 | € 204,795 | ▲ 14% |
| Profit after taxes | € 6,153 | € 31,544 | € 20,750 | € 40,480 | ▲ 95% |
| Equity | € 533,843 | € 519,387 | € 492,137 | € 440,811 | ▼ 10% |
| Total debts | € 142,281 | € 101,078 | € 104,044 | € 138,041 | ▲ 33% |
| Cash | € 188,010 | € 86,961 | € 169,972 | € 161,002 | ▼ 5% |
| Retained profit | € 515,251 | € 500,795 | € 473,545 | € 422,219 | ▼ 11% |
| Dividend | € 35,500 | € 45,000 | € 47,000 | € 90,000 | ▲ 91% |
| Bank debt | € 8,583 | € 3,482 | € 1,681 | € 0 | ▼ 100% |
| Balance sheet total | € 676,124 | € 620,465 | € 596,182 | € 578,852 | ▼ 3% |
| Employees (FTE) | 1.7 | 1.5 | 1.5 | 1.5 |
Key figures of PHARMACIE DU VALDUC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DU VALDUC?
What happened at PHARMACIE DU VALDUC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Corrected annual accounts filed for financial year 2025. Source: NBB ↗
- CARVI CONSULT SRL became a director. NBB
- New establishment in Oudergem. KBO
- Start of the company according to the CBE. KBO
- VINCENT LANGOUCHE became a director. NBB
In short
From € 6,153 profit in 2022 to € 40,480 profit in 2025.
Paid € 32,414 in corporate taxes since 2022.
Best year ever: 2025, with € 40,480 profit.
On average € 136,500 of value added per employee in 2025.
A new publication or filing at PHARMACIE DU VALDUC? We notify you, reason included.
Follow PHARMACIE DU VALDUCDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE DU VALDUC are VINCENT LANGOUCHE and CARVI CONSULT SRL. VINCENT LANGOUCHE is also behind CARVI CONSULT.
Directors
According to the 2025 annual accounts
since 1998
Director · represented by CAROLINE BUYCK
since 2022
Establishments
Establishment units
Physical locations of this company
Rue Edouard Dinot 32
5590 Ciney
Waverse steenweg 1461
1160 Oudergem
Active since 16 April 1998
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 18 companies are registered at this address.
All companies at this address →L'Economie Populaire
€ 172.9 million revenue · 2025
Familia Real Estate
Respectable Vehicle Collectors Club
Pharmacie de la Semois
€ 261,046 gross margin · 2025
PHARMACIE SANTIS DES CORETTES
€ 288,944 gross margin · 2025
+13 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0462.999.311
- VAT number
- BE 0462.999.311
- Registered office
- Rue Edouard Dinot 32, 5590 Ciney
- Names & denominations
- PHARMACIE DU VALDUC
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 31 March 1998
- Peppol
- Active · Active since 3 Aug 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers